Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Tolmetin Sodium from Atland Pharmaceuticals, LLC, updating an existing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolmetin sodium (Tolmetin sodium)

Snippet

SUPPL AP for TOLMETIN SODIUM (TOLMETIN SODIUM)